Quotient Therapeutics signs agreement with Pfizer for two exploratory research programmes
Quotient Therapeutics, which is headquartered in both Cambridge, MA and Cambridge, UK – and its lead investor, Flagship Pioneering – have signed an agreement with Pfizer for two exploratory research programmes. Founded in 2022 by Massachusetts-based life …